Oncoinfluencers to Follow on Social Media: Dr. Michael Wang
At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician in the field of lymphoma, as our next oncoinfluencer.
Dr. Wang is active on X/Twitter, where he shares his expertise and updates on the latest advancements in lymphoma research. His posts provide valuable insights into preclinical and clinical research, particularly in Mantle Cell Lymphoma (MCL). His frequent updates and thought-provoking contributions make him a must-follow for anyone interested in lymphoma research and treatment.
Stay updated with Dr. Wang’s latest research and insights by following him on social media:
X/Twitter: @michaelwangmd
About Michael Wang
Michael Wang is a Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, where he focuses on preclinical and clinical research. He established the first human primary Mantle Cell Lymphoma (MCL) animal model, the MCL-SCID-hu mouse model, for studying the biology and treatment of MCL.
Dr. Wang has published over 150 peer-reviewed papers and has presented his work at national and international meetings. He is the current Director of the MCL Program of Excellence and Co-Director of Clinical Trials at MD Anderson. Additionally, he holds a joint appointment as a Professor in the Department of Stem Cell Transplantation at the same institution.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website on influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023